NEU 3.20% $18.58 neuren pharmaceuticals limited

Ann: Comment on research report, page-270

  1. 2,573 Posts.
    lightbulb Created with Sketch. 397
    Maybe that’s why they waited to develop Fragile X - makes sense to go through and spend on trials with the perceived better drug.


    Last edited by good1234: 21/02/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.